THE WHAT? Macy’s has reported FY2021 comparable sales up 43 percent on an owned basis and up 42.9 percent on an owned-plus-licensed basis versus 2020; up 3.1 percent and up 3 percent, respectively, versus 2019.
THE DETAILS The U.S. retailer saw digital sales increase 13 percent versus 2020 and increase 39 percent compared to 2019.
Looking at Q4, Macy’s saw comparable sales rise 28.3 percent on an owned basis and up 27.8 percent on an owned-plus-licensed basis versus the fourth quarter of 2020; up 6.6 percent and 6.1 percent, respectively, compared to Q4 2019.
Digital sales increased 12 percent in Q4, while Macy’s new customers increased 40 percent over 2020 and 26 percent over 2019 to 19.4 million.
The better-than-expected results mean Macy’s has declined to spin off its online business, which is said to be being pushed by an activist investor.
Chief Executive Jeff Gennette told Reuters, “We are more confident in our path forward as one integrated company.”
THE WHY? Macy’s offset any disruption from the COVID-19 Omicron variant with higher prices and speeding up shipments for the holiday quarter.
Gennette said, “Our team began the large-scale work of transforming Macy’s, Inc. two years ago when we launched the Polaris strategy, and today we believe the evidence is clear – our business is stronger, more agile, and financially healthier. We are more digitally led and customer centric and believe we are better positioned for long-term sustainable and profitable growth.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
